FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2532100504> ?p ?o ?g. }

• W2532100504 endingPage "1271" @default.
• W2532100504 startingPage "1255" @default.
• W2532100504 abstract "Several newer antiepileptic drugs (AEDs) have been introduced into clinical practice, offering choices for individualizing the treatment of epilepsy since AEDs have different efficacy and tolerability profiles. In particular, questions exist regarding which AEDs are the best options for the monotherapy of focal epilepsy. Is carbamazepine (CBZ), which is considered the standard treatment for focal epilepsy, still the best option for monotherapy of focal epilepsy, despite the emergence of new AEDs? In this systematic review, we compared the relative tolerability of all available AEDs for monotherapy of all types of epilepsy as well as their efficacy in the monotherapy of focal epilepsy. In addition, we compared CBZ with other AEDs for the monotherapy of focal epilepsy. We performed a search of the MEDLINE/PubMed, Scopus, Web of Science, and Cochrane Central Register of Controlled Trials (CENTRAL) databases for randomized controlled clinical trials. To compare the relative efficacy and tolerability of the AEDs, we performed network meta-analyses using a Bayesian random-effects model. Sensitivity analyses were conducted to determine the robustness of the results. A total of 65 studies were included in this review, composing 16,025 patients. Clobazam, levetiracetam, lamotrigine, oxcarbazepine, sulthiame, topiramate, and valproate had the best efficacy profiles and demonstrated no evidence of superiority or inferiority compared with CBZ. However, CBZ showed the greatest risk of patient discontinuation due to intolerable adverse reactions, whereas lamotrigine had the best safety profile and an 81% probability of being the best for the tolerability outcome of patient withdrawals from the study due to intolerable adverse reactions, followed by sulthiame (60%) and clobazam (51%). The newer AEDs-levetiracetam, lamotrigine, oxcarbazepine, sulthiame, and topiramate-should be considered for monotherapy of focal epilepsy because they were demonstrated to be as effective as the older ones (CBZ, clobazam, and valproate) for the treatment of focal epilepsy and were more tolerable. Lamotrigine was the AED with the best tolerability profile, suggesting that it may be the best option for the treatment of focal epilepsy in children and adults." @default.
• W2532100504 created "2016-10-28" @default.
• W2532100504 creator A5011287104 @default.
• W2532100504 creator A5029524156 @default.
• W2532100504 creator A5053602710 @default.
• W2532100504 creator A5062138940 @default.
• W2532100504 creator A5084164632 @default.
• W2532100504 date "2016-12-01" @default.
• W2532100504 modified "2023-10-16" @default.
• W2532100504 title "Efficacy and Tolerability of Antiepileptic Drugs in Patients with Focal Epilepsy: Systematic Review and Network Meta-analyses" @default.
• W2532100504 cites W1599565459 @default.
• W2532100504 cites W1605074829 @default.
• W2532100504 cites W1732466172 @default.
• W2532100504 cites W1951203427 @default.
• W2532100504 cites W1965450907 @default.
• W2532100504 cites W1970717865 @default.
• W2532100504 cites W1973019762 @default.
• W2532100504 cites W1982228885 @default.
• W2532100504 cites W1983021024 @default.
• W2532100504 cites W1993756785 @default.
• W2532100504 cites W1994457839 @default.
• W2532100504 cites W2002407252 @default.
• W2532100504 cites W2005501262 @default.
• W2532100504 cites W2010699829 @default.
• W2532100504 cites W2012659256 @default.
• W2532100504 cites W2015221399 @default.
• W2532100504 cites W2017212385 @default.
• W2532100504 cites W2020209883 @default.
• W2532100504 cites W2026750272 @default.
• W2532100504 cites W2026842657 @default.
• W2532100504 cites W2027242474 @default.
• W2532100504 cites W2028500192 @default.
• W2532100504 cites W2032677433 @default.
• W2532100504 cites W2032973687 @default.
• W2532100504 cites W2037222801 @default.
• W2532100504 cites W2039418122 @default.
• W2532100504 cites W2039674635 @default.
• W2532100504 cites W2044333796 @default.
• W2532100504 cites W2045274557 @default.
• W2532100504 cites W2047200977 @default.
• W2532100504 cites W2052378771 @default.
• W2532100504 cites W2056983769 @default.
• W2532100504 cites W2058147010 @default.
• W2532100504 cites W2061631141 @default.
• W2532100504 cites W2064482573 @default.
• W2532100504 cites W2066622149 @default.
• W2532100504 cites W2072923583 @default.
• W2532100504 cites W2075552514 @default.
• W2532100504 cites W2076662133 @default.
• W2532100504 cites W2085059524 @default.
• W2532100504 cites W2086001349 @default.
• W2532100504 cites W2087316575 @default.
• W2532100504 cites W2087388267 @default.
• W2532100504 cites W2095558066 @default.
• W2532100504 cites W2096742584 @default.
• W2532100504 cites W2097462102 @default.
• W2532100504 cites W2098517987 @default.
• W2532100504 cites W2098977267 @default.
• W2532100504 cites W2113091762 @default.
• W2532100504 cites W2113144077 @default.
• W2532100504 cites W2114002180 @default.
• W2532100504 cites W2116043268 @default.
• W2532100504 cites W2123177504 @default.
• W2532100504 cites W2123287446 @default.
• W2532100504 cites W2124279185 @default.
• W2532100504 cites W2127687792 @default.
• W2532100504 cites W2132785864 @default.
• W2532100504 cites W2138521331 @default.
• W2532100504 cites W2139992285 @default.
• W2532100504 cites W2140131270 @default.
• W2532100504 cites W2140540336 @default.
• W2532100504 cites W2140792819 @default.
• W2532100504 cites W2144625636 @default.
• W2532100504 cites W2144888247 @default.
• W2532100504 cites W2147003023 @default.
• W2532100504 cites W2147974822 @default.
• W2532100504 cites W2152366304 @default.
• W2532100504 cites W2155517463 @default.
• W2532100504 cites W2157291067 @default.
• W2532100504 cites W2160653335 @default.
• W2532100504 cites W2164777277 @default.
• W2532100504 cites W2166522334 @default.
• W2532100504 cites W2168075369 @default.
• W2532100504 cites W2168120312 @default.
• W2532100504 cites W2168915562 @default.
• W2532100504 cites W2169966598 @default.
• W2532100504 cites W2320058521 @default.
• W2532100504 cites W2431118687 @default.
• W2532100504 cites W2503193180 @default.
• W2532100504 cites W4246199030 @default.
• W2532100504 cites W91411697 @default.
• W2532100504 doi "https://doi.org/10.1002/phar.1855" @default.
• W2532100504 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27779771" @default.
• W2532100504 hasPublicationYear "2016" @default.
• W2532100504 type Work @default.
• W2532100504 sameAs 2532100504 @default.
• W2532100504 citedByCount "29" @default.
• W2532100504 countsByYear W25321005042017 @default.

• next